Trial site
Pectus Respiratory Health S.L.
- 13running trials
- 8closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Asthma12 trials
- Idiopathic pulmonary fibrosis5 trials
- COPD4 trials
- Bronchiectasis1 trial
- Cystic fibrosis1 trial
- Phase
- Phase 39 trials
- Phase 27 trials
- Phase 1/22 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Completed8 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Not yet recruiting4 trials
- Lead sponsor
- GlaxoSmithKline5 trials
- Sanofi3 trials
- LETI Pharma S.L.U.2 trials
- Areteia Therapeutics Inc.1 trial
- Arrowhead Pharmaceuticals1 trial
- and 9 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma4 recruiting
- COPD3 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026